Cargando…
Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma
PURPOSE: To seek novel diagnostic approaches, we improved the workflow of cell-free DNA (cfDNA) sequencing and evaluated its feasibility in vitreoretinal lymphoma (VRL) specimens; the profile of mutations was preliminarily analyzed for potential diagnostic value. METHODS: The study was a diagnostic...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343589/ https://www.ncbi.nlm.nih.gov/pubmed/35928872 http://dx.doi.org/10.3389/fonc.2022.932674 |
_version_ | 1784761023426723840 |
---|---|
author | Gu, Junxiang Jiang, Tingting Liu, Shixue Ping, Bo Li, Ruiwen Chen, Wenwen Wang, Ling Huang, Xin Xu, Gezhi Chang, Qing |
author_facet | Gu, Junxiang Jiang, Tingting Liu, Shixue Ping, Bo Li, Ruiwen Chen, Wenwen Wang, Ling Huang, Xin Xu, Gezhi Chang, Qing |
author_sort | Gu, Junxiang |
collection | PubMed |
description | PURPOSE: To seek novel diagnostic approaches, we improved the workflow of cell-free DNA (cfDNA) sequencing and evaluated its feasibility in vitreoretinal lymphoma (VRL) specimens; the profile of mutations was preliminarily analyzed for potential diagnostic value. METHODS: The study was a diagnostic trial. 23 eyes of 23 patients with VRL and 25 eyes of 25 patients with inflammatory eye diseases were enrolled. Approximate 500μl undiluted vitreous humor and 10ml diluted vitreous fluid was obtained through diagnostic vitrectomy and sent for cytopathological examinations. 500μl of the diluted vitreous fluid was spared for cfDNA sequencing. For cfDNA sequencing, DNA fragmentation procedure was added to the workflow to improve the extraction efficiency; mutations detected were analyzed for potential diagnostic model. The sensitivity and specificity of the cytopathology and cfDNA sequencing were compared. The clinical manifestations were preliminarily analyzed for potential correlations with the genotypes. RESULTS: CfDNA sequencing was accomplished in 23 eyes with VRL and 20 eyes with inflammatory eye diseases. VRL-related mutated genes included MYD88 (18 eyes, 78%), ETV6 (11 eyes, 48%), PIM1 (11 eyes,48%), BTG2 (7 eyes, 30%), IRF4 (7 eyes, 30%), CD79B (6 eyes, 26%), LRP1B (6 eyes, 26%), etc. Logistic regression based on the mutations of MYD88 and ETV6 was of the potential for the diagnosis of VRL (P<0.001, adjusted R2 = 0.789, sensitivity 0.913, specificity 0.950); by comparison, the sensitivity and specificity of the vitreous cytopathology were 0.826 and 1.000, respectively. Further analysis of the mutation profile showed that patients carrying CD79B mutation tended to have higher intraocular interleukin-10 level (P=0.030), that CARD11 mutation was correlated with younger age at ocular onset (P=0.039), and that patients with intracranial involvement carried more multiple-site mutations in the BTG2 gene (P=0.013). CONCLUSIONS: The improved workflow of CfDNA sequencing is of sound feasibility in a limited amount of vitreous humor. The logistic model based on the mutations could help to provide reliable clues for the diagnosis of VRL. |
format | Online Article Text |
id | pubmed-9343589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93435892022-08-03 Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma Gu, Junxiang Jiang, Tingting Liu, Shixue Ping, Bo Li, Ruiwen Chen, Wenwen Wang, Ling Huang, Xin Xu, Gezhi Chang, Qing Front Oncol Oncology PURPOSE: To seek novel diagnostic approaches, we improved the workflow of cell-free DNA (cfDNA) sequencing and evaluated its feasibility in vitreoretinal lymphoma (VRL) specimens; the profile of mutations was preliminarily analyzed for potential diagnostic value. METHODS: The study was a diagnostic trial. 23 eyes of 23 patients with VRL and 25 eyes of 25 patients with inflammatory eye diseases were enrolled. Approximate 500μl undiluted vitreous humor and 10ml diluted vitreous fluid was obtained through diagnostic vitrectomy and sent for cytopathological examinations. 500μl of the diluted vitreous fluid was spared for cfDNA sequencing. For cfDNA sequencing, DNA fragmentation procedure was added to the workflow to improve the extraction efficiency; mutations detected were analyzed for potential diagnostic model. The sensitivity and specificity of the cytopathology and cfDNA sequencing were compared. The clinical manifestations were preliminarily analyzed for potential correlations with the genotypes. RESULTS: CfDNA sequencing was accomplished in 23 eyes with VRL and 20 eyes with inflammatory eye diseases. VRL-related mutated genes included MYD88 (18 eyes, 78%), ETV6 (11 eyes, 48%), PIM1 (11 eyes,48%), BTG2 (7 eyes, 30%), IRF4 (7 eyes, 30%), CD79B (6 eyes, 26%), LRP1B (6 eyes, 26%), etc. Logistic regression based on the mutations of MYD88 and ETV6 was of the potential for the diagnosis of VRL (P<0.001, adjusted R2 = 0.789, sensitivity 0.913, specificity 0.950); by comparison, the sensitivity and specificity of the vitreous cytopathology were 0.826 and 1.000, respectively. Further analysis of the mutation profile showed that patients carrying CD79B mutation tended to have higher intraocular interleukin-10 level (P=0.030), that CARD11 mutation was correlated with younger age at ocular onset (P=0.039), and that patients with intracranial involvement carried more multiple-site mutations in the BTG2 gene (P=0.013). CONCLUSIONS: The improved workflow of CfDNA sequencing is of sound feasibility in a limited amount of vitreous humor. The logistic model based on the mutations could help to provide reliable clues for the diagnosis of VRL. Frontiers Media S.A. 2022-07-19 /pmc/articles/PMC9343589/ /pubmed/35928872 http://dx.doi.org/10.3389/fonc.2022.932674 Text en Copyright © 2022 Gu, Jiang, Liu, Ping, Li, Chen, Wang, Huang, Xu and Chang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Gu, Junxiang Jiang, Tingting Liu, Shixue Ping, Bo Li, Ruiwen Chen, Wenwen Wang, Ling Huang, Xin Xu, Gezhi Chang, Qing Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma |
title | Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma |
title_full | Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma |
title_fullStr | Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma |
title_full_unstemmed | Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma |
title_short | Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma |
title_sort | cell-free dna sequencing of intraocular fluid as liquid biopsy in the diagnosis of vitreoretinal lymphoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343589/ https://www.ncbi.nlm.nih.gov/pubmed/35928872 http://dx.doi.org/10.3389/fonc.2022.932674 |
work_keys_str_mv | AT gujunxiang cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma AT jiangtingting cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma AT liushixue cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma AT pingbo cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma AT liruiwen cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma AT chenwenwen cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma AT wangling cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma AT huangxin cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma AT xugezhi cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma AT changqing cellfreednasequencingofintraocularfluidasliquidbiopsyinthediagnosisofvitreoretinallymphoma |